Rachel Vaknin
2022
In 2022, Rachel Vaknin earned a total compensation of $234.6K as CFO at StemCells.
Compensation breakdown
| Option Awards | $45,263 |
|---|---|
| Salary | $189,384 |
| Total | $234,647 |
Vaknin received $189.4K in salary, accounting for 81% of the total pay in 2022.
Vaknin also received $45.3K in option awards.
Rankings
In 2022, Rachel Vaknin's compensation ranked 5,302nd out of 5,760 executives tracked by ExecPay. In other words, Vaknin earned more than 8.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,302 out of 5,760 | 8th |
Division Manufacturing | 2,905 out of 3,136 | 7th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 437 out of 485 | 10th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 315 out of 347 | 9th |
Industry Surgical and Medical Instruments and Apparatus | 231 out of 253 | 9th |
Source: SEC filing on September 19, 2023.
Vaknin's colleagues
We found three more compensation records of executives who worked with Rachel Vaknin at StemCells in 2022.